Barclays starts ABT at Overweight with Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Barclays initiated coverage on Abbott Laboratories (ABT) with an Overweight rating and a Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Barclays initiated coverage on Abbott Laboratories (ABT) with an Overweight rating and a Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context